Participants 482 576 6
Thirty nonbleeding patients with international normalized ratios (INRs) ranging from 6.0-10.0.
Participants 1515 1558 3
asymptomatic patients with INRs of 6.0-10.0
Participants 1606 1758 3
patients at high risk for bleeding in whom the benefit of prompt INR reduction would outweigh the thromboembolic risk associated with INR overcorrection
